Evaluation of Heart Failure Telemonitoring Eligibility Criteria

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 130

Sponsor: University Hospital, Clermont-Ferrand

Summary

CARDIAUVERGNE is a heart failure telemonitoring system at Clermont-Ferrand's hospital. The aim of this study is to analyze the prognosis and evolution of patients after exclusion of telemonitoring. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the French health authority criteria.

Eligibility Criteria

Inclusion Criteria: * adults * able to read and understand french * included in CARDIAUVERGNE telemonitoring program from 1st january 2023 to 31st december 2024 such as defined by the french health authorithy criteria (heart failure within 12 months or dyspnea at least NYHA 2 associated with NTproBNP of at least 1000pg/mL) and excluded by medical decision as no longer presenting eligibillity criteria Exclusion Criteria: * Patients leaving telemonitoring for other reasons (choice, death, medical reason, relocation, inobservance)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07278583). StuddyBuddy aggregates publicly available trial information.